Advertisements


Piper remains Overweight on Audentes following "impressive" data update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Piper Jaffray remains Overweight on Audentes after positive "AT132" update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 6th, 2019

Piper remains bullish on MorphoSys after L-MIND data update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 20th, 2019

Piper backs Overweight on Array BioPharma after "impressive" BEACON update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Sutro Biopharma ovarian cancer data "impressive," says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 20th, 2021

Piper Sandler remains bullish on Catalyst following Q1 results, pipeline update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 11th, 2021

Ionis" Phase 2 data for PKK-LRx "impressive" at face value, says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2021

Piper Sandler remains buyer of Amgen following asthma data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 1st, 2021

Piper remains "bullish" on Immunic progress with IMU-838 after Q4 update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2021

Piper Sandler remains a buyer of Akebia following Phase 3 INNO2VATE data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 5th, 2020

Piper Sandler reiterates Overweight rating on Moderna after operations update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 30th, 2020

Incyte data on topical ruxolitinib "impressive," says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Exelixis data "impressive," support accelerated approval, says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2020

Exelixis data "impressive," support accelerated approval, says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2020

Piper Jaffray reiterates Overweight on Agios after "encouraging" SNO update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 24th, 2019

Piper remains buyer of Audentes following AT845 trial design disclosure

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 22nd, 2019

Piper Jaffray reiterates Overweight on Iovance after SITC update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 10th, 2019

Piper Jaffray reiterates Overweight on Alnylam after data presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 10th, 2019

RBC remains buyer of Constellation into 110% rally after "impressive" data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 6th, 2019

Rocket Pharmaceuticals data update "incrementally positive," says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2019

Deciphera data update "derisking" ahead of 2020 filing, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 30th, 2019